VERU INC. Loss Contingency Accrual, Period Increase (Decrease)
VERU INC. (VERU) reported Loss Contingency Accrual, Period Increase (Decrease) of $0 for the 12-month period ending 2019-09-30, per its 10-K filed 2019-12-12.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease · last filed 2019-12-12
- VERU INC. loss contingency accrual, period increase (decrease) for the quarter ending 2019-09-30 was $0.00.
- VERU INC. loss contingency accrual, period increase (decrease) for the quarter ending 2018-09-30 was $0.00.
- VERU INC. loss contingency accrual, period increase (decrease) for the quarter ending 2018-06-30 was $0.00.
- VERU INC. loss contingency accrual, period increase (decrease) for the quarter ending 2018-03-31 was $0.00.
- VERU INC. loss contingency accrual, period increase (decrease) for fiscal 2019 was $0.00.
- VERU INC. loss contingency accrual, period increase (decrease) for fiscal 2018 was $0.00.
| Period end | Loss Contingency Accrual, Period Increase (Decrease) 3 month | Loss Contingency Accrual, Period Increase (Decrease) 6 month | Loss Contingency Accrual, Period Increase (Decrease) 9 month | Loss Contingency Accrual, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $0.00 10-K · filed 2019-12-12 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $0.00 derived: sum of 2 quarters · filed 2018-12-13 | $0.00 derived: sum of 3 quarters · filed 2018-12-13 | $0.00 10-K · filed 2018-12-13 |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $0.00 derived: sum of 2 quarters · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $0.00 10-Q · filed 2018-05-11 | ||
| 2017-12-31 | $0.00 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |